An artificial intelligence model to predict the ideal time for ruptured brain aneurysm treatment to prevent re-rupture of the aneurysm prior to its treatment.

Not Applicable

• Conditions: Aneurysmal subarachnoid haemorrhage; Stroke - Haemorrhagic

• Registration Number: ACTRN12623000986673
• Lead Sponsor: Department of Neurosurgery

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-09-11
• Last Update Posted: 18 September 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 1009

Inclusion Criteria

The Sir Charles Gairdner Hospital (SCGH) saccular aneurysmal subarachnoid haemorrhage database contains prospectively collected data for patients 18 years or over admitted to SCGH in Nedlands, Western Australia (WA) between 1st January 2009 and 31st December 2022 inclusive with aneurysmal SAH confirmed using either non-contrast computerised tomography (CT) brain scanning and/or cerebrospinal fluid spectroscopic analysis due to the rupture of a singular culprit saccular cerebral aneurysm as identified on CT-angiography, magnetic resonance angiography and/or digital subtraction catheter angiography.

Exclusion Criteria

Patients were excluded from the study population if they experienced cryptogenic subarachnoid haemorrhage (SAH), peri-mesencephalic SAH, SAH due to arterial dissection, fusiform, mycotic or blister type aneurysm, recurrent SAH from a previously treated saccular aneurysm or SAH due to a ruptured arteriovenous malformation.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pre-treatment rebleeding following single saccular aneurysmal subarachnoid hemorrhage. An episode of pre-treatment rebleeding is defined as a sudden deterioration in the consciousness state or a sudden increase in headache with an elevation of systolic blood pressure together with an increase in acute blood seen on a computerised tomography (CT) brain scan. This will be ascertained by scrutiny of participant discharge summaries as well as electronic radiology imaging including reports and request forms.[ Using data collected up to and including 31st December 2022]